With the funding, Takeda plans to develop, license and supply at least 50 million doses of Sabin-strain inactivated poliovirus vaccine each year to more than 70 developing nations. The polio eradication effort is part of Takeda’s attempt to address global public health and meet the Sustainable Development Goals adopted by the United Nations in September 2015.
“In 2016, the world is closer than ever to eradicating polio,” said Chris Elias, president of global development at the Bill & Melinda Gates Foundation. “To eradicate polio we need to ensure every last child is protected from the disease — this partnership will help to ensure that the world has enough vaccine to get the job done and maintain a polio-free world.”
More articles on polio:
First-ever worldwide polio vaccine switch attempted
Johns Hopkins physician and pioneer in reproductive medicine dies at 104
Sir Liam Donaldson | 50 Experts Leading the Field of Patient Safety 2015
